- A011401 BWEL (Breast)
A Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer: Stage II /III within 1 year of diagnosis
- A011502 ABC Trial (Breast)
Phase III Randomized double blinded placebo-controlled trial of aspirin as adjuvant therapy for Her 2 Negative breast cancer STAGE II OR III
- A021502 ATOMIC (Colon)
A Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
- A031501 AMBASSADOR (Urothelial)
A Phase III Randomized Adjuvant Study of MK-3475 (PEMBROLIZUMAB) in Muscle Invasive and Locally Advanced Urothelial Carcinoma versus Observation
- A051701 (Lymphoma)
A Randomized Phase II/III Study of Venetoclax (ABT199) plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
- A151216 ALCHEMIST (Lung)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST): A screening trial for A081105, E4512 and EA5142
- DCP-001 (Any Cancer)
Clinical trial DCP-001 at the Harold Alfond Center for Cancer Care: Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
- E4512 ALCHEMIST - SUBSTUDY (Lung)
A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib vs. Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
- EA8143 PROSPER RCC (Renal)
A Phase III RandOmized Study Comparing PERioperative NIVOLUMAB vs. OBSERVATION in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy
- EA8153 CHAARTED2 (Prostate)
Cabazitaxel with Abiraterone versus Abiraterone alone Randomized Trial for Extensive Disease following Docetaxel
